DECHRA VETERINARY PRODUCTS A/S: Financial statements 2025
CVR: 10114241
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
DECHRA VETERINARY PRODUCTS A/S (CVR 10114241) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 2,875,016,000 and a net result of DKK 189,967,000 compared with DKK 116,939,000 the year before. That is an increase of 7.2% compared with the year before. The profit margin was 6.6%. Equity in the 2025 report amounted to DKK 571,636,000. The solvency ratio was 45.3%. The company had 131 employees in the financial year.
- Revenue
- DKK 2,875,016,000
- Gross Profit
- DKK 253,516,000
- Profit/Loss
- DKK 189,967,000
- Equity
- DKK 571,636,000
- Total Assets
- DKK 1,260,746,000
- Employees
- 131
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 2.9B | 253.5M | 190M | 571.6M | 131 |
| 2024 | 2.7B | 240.9M | 116.9M | 631.7M | 108 |
| 2023 | 2.5B | 238.9M | 129.7M | 688.9M | 110 |
| 2022 | 2.4B | 255.8M | 157.6M | 560.4M | 108 |
| 2021 | 2.1B | 192.2M | 98.3M | 403.1M | 98 |
Official annual report
How creditworthy is DECHRA VETERINARY PRODUCTS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of May 13, 2025, Ajay Gandhi has joined the board of directors of DECHRA VETERINARY PRODUCTS A/S.
As of May 13, 2025, Paul Nicholas Sandland has left the board of directors of DECHRA VETERINARY PRODUCTS A/S.
DECHRA VETERINARY PRODUCTS A/S has published its annual report for 2024. Revenue came to DKK 2,680,690,000, and the net result was DKK 116,939,000.
About DECHRA VETERINARY PRODUCTS A/S
DECHRA VETERINARY PRODUCTS A/S is a Danish company of the type Aktieselskab based in Uldum, founded in 1986. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETXX A/S and LEO ANIMAL HEALTH A/S. The management consists of Ian Machan Mackellar. The board consists of Ajay Gandhi (chair), Ian Machan Mackellar and Robert Mark Leather. The company is owned by Dechra Pharmaceuticals Limited. The company has 122 employees (2026). In 2025, the company reported revenue of DKK 2,875,016,000 and a net result of DKK 189,967,000 compared with DKK 116,939,000 the year before. Equity in the 2025 report amounted to DKK 571,636,000.
